Organisms | Evidence |
---|---|
Mus musculus (house mouse) | |
Rattus norvegicus (Norway rat) | |
Homo sapiens (human) | |
Drosophila melanogaster (fruit fly) | |
Streptococcus pneumoniae |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT1 | UDP-Gal |
|
R |
|
R | |
B3GALT5 | UDP-Gal |
|
R |
|
R |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
Pathway Name | Organism |
---|---|
Lectin pathway of complement activation | Rattus norvegicus |
Lectin pathway of complement activation | Homo sapiens |
Lectin pathway of complement activation | Canis familiaris |
Lectin pathway of complement activation | Sus scrofa |
Lectin pathway of complement activation | Bos taurus |
Lectin pathway of complement activation | Mus musculus |
Lectin pathway of complement activation | Gallus gallus |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
33427997 | Potassium-induced partial inhibition of lactoperoxidase: structure of the complex of lactoperoxidase with potassium ion at 2.20 Å resolution | Singh PK | 2021 Jan 11 |
|
33431842 | Stabilizing the closed SARS-CoV-2 spike trimer | Juraszek J | 2021 Jan 11 |
|
33432245 | Cryo-EM structures of Toll-like receptors in complex with UNC93B1 | Ishida H | 2021 Jan 11 |
|
33432247 | A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent | Xiao T | 2021 Jan 11 |
|
33431856 | Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry | Ge J | 2021 Jan 11 |
|
33422108 | Increased O-GlcNAcylation of Drp1 by amyloid-beta promotes mitochondrial fission and dysfunction in neuronal cells | Park SJ | 2021 Jan 09 |
|
33437137 | Combination and tricombination therapy to destabilize the structural integrity of COVID-19 by some bioactive compounds with antiviral drugs: insights from molecular docking study | El-Mageed HRA | 2021 Jan 08 |
|
33420071 | Structures of human dual oxidase 1 complex in low-calcium and high-calcium states | Wu J | 2021 Jan 08 |
|
33214287 | Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth | Roark RS | 2021 Jan 08 |
|
33420048 | Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes | Song X | 2021 Jan 08 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025